Granules India informs about press release

17 Dec 2024 Evaluate
Granules India has informed that it enclosed press release ‘Granules India Limited Announces FDA Approval for ADHD Treatment, Addressing Drug Shortages in the US’.

The above information is a part of company’s filings submitted to BSE.

Granules India Share Price

599.70 1.00 (0.17%)
24-Feb-2026 11:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1731.85
Dr. Reddys Lab 1305.00
Cipla 1328.80
Zydus Lifesciences 906.20
Lupin 2246.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×